ResearcherGuiyang Medical UniversityActive in the last 2 years
Chengyi Sun
Matched on OpenAlex author ID A5101187938. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. Co-author DOI 10.1038/s41598-025-88265-0↗
- Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomato… Last author DOI 10.21037/jgo-23-198↗
- CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of P… Last author DOI 10.7150/jca.69617↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuting Guo · 2 shared papers, 2022–2023 · strength 0.51
- Paper Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancrea… DOI 10.21037/jgo-23-198↗
- Paper CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Prol… DOI 10.7150/jca.69617↗
- Shiyu Chen · 1 shared paper, 2025 · strength 0.28
- Zhiwei He · 1 shared paper, 2025 · strength 0.28
- Chao Yu · 1 shared paper, 2025 · strength 0.28
- Changhao Wu · 1 shared paper, 2025 · strength 0.28
- She Tian · 1 shared paper, 2022 · strength 0.20
- Dan Li · 1 shared paper, 2022 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.